A case of familial pulmonary mycobacterium avium complex disease

Internal Medicine

Volumn 49, Issue 10, 2010, Pages 949-953

  Matsuyama, Masashi ^a   Miura, Yukiko ^a   Kiwamoto, Takumi ^a   Moriya, Ataru ^a   Kokuho, Nariaki ^a   Shimizu, Kei ^a   Otsuka, Shigeo ^a   Hijikata, Minako ^b   Keicho, Naoto ^b   Hayashihara, Kenji ^a   Saito, Takefumi ^a  

^a The Center of Chest Diseases and Severe Motor Intellectual Disabilities   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

CFTR; Familial pulmonary mycobacterium avium complex disease; HLA A26 antigen; Menopause; NRAMP1

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; HLA A ANTIGEN; HLA A26 ANTIGEN; LEVOFLOXACIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; RIFAMPICIN; STREPTOMYCIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BRONCHIECTASIS; CLINICAL ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE EXACERBATION; FAMILIAL DISEASE; FEMALE; GENDER; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HLA TYPING; HUMAN; JAPANESE; LUNG INFECTION; LUNG NODULE; MALE; MENOPAUSE; MYCOBACTERIUM AVIUM;

ADULT; AGED; CATION TRANSPORT PROTEINS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A ANTIGENS; HUMANS; JAPAN; MALE; MENOPAUSE; MIDDLE AGED; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PEDIGREE; RISK FACTORS;

EID: 77952900672     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.3023     Document Type: Article

References (15)

1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/ IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416, 2007.
2. Tanaka E, Kimoto T, Matsumoto H, et al. Familial pulmonary Mycobacterium avium complex disease. Am J Respir Crit Care Med 161: 1643-1647, 2000.
3. Inoue T, Tanaka E, Sakuramoto M, et al. Three sisters of pulmonary Mycobacterium avium complex disease. Kansenshogaku Zasshi 79: 341-347, 2005 (in Japanese).
4. Sexton P, Harrison AC. Susceptibility to nontuberculous mycobacterial lung disease. Eur Respir J 31: 1322-1333, 2008.
5. Kim RD, Greenberg DE, Ehrmantraut ME, et al. Pulmonary non-tuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 178: 1066-1074,2008.
6. Mai HN, Hijikata M, Inoue Y, et al. Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene. Int J Tuberc Lung Dis 11: 808-813, 2007.
7. Ziedalski TM, Kao PN, Henig NR, et al. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 130: 995-1002, 2006.
8. Tanaka G, Shojima J, Matsushita I, et al. Pulmonary Mycobacterium avium complex infection: association with NRAMP1 polymorphisms. Eur Respir J 30: 90-96, 2007.
9. Kubo K, Yamazaki Y, Hanaoka M, et al. Analysis of HLA antigens in Mycobacterium aviumintracellulare pulmonary infection. Am J Respir Crit Care Med 161: 1368-1371, 2000.
10. Takahashi M, Ishizaka A, Nakamura H, et al. Specific HLA in pulmonary MAC infection in a Japanese population. Am J Respir Crit Care Med 162: 316-318, 2000.
11. Um SW, Ki CS, Kwon OJ, et al. HLA antigens and nontuberculous mycobacterial lung disease in Korean patients. Lung 187: 136-140, 2009.
12. Caillouette JC, Sharp CF Jr, Zimmerman GJ, et al. Vaginal pH as a marker for bacterial pathogens and menopausal status. Am J Obstet Gynecol 176: 1270-1275, 1997.
13. Tsuyuguchi K, Suzuki K, Matsumoto H, et al. Effect of estrogen on Mycobacterium avium complex pulmonary infection in mice. Clin Exp Immunol 123: 428-434, 2001.
14. Yamashiro Y, Shimizu T, Oguchi S, et al. The estimated incidence of cystic fibrosis in Japan. J Pediatr Gastroenterol Nutr 24: 544-547,1997.
15. Plouffe JF, Silva J Jr, Fekety R, et al. Cell-mediated immunity in diabetes mellitus. Infect Immun 21: 425-429, 1978.